Abstract
For biophysical studies using heteronuclear NMR analysis of amyloid beta peptide, construction of an efficient and high yield expression system of uniformly isotopic labeled amyloid beta peptide is desirable. Here we succeeded in obtaining 15N-labeled amyloid beta 1-40 expressed by attachment to hen egg white lysozyme as a fusion protein.
Keywords: Alzheimer's disiease, amyloid β 1-40, amyloid fibrils, recombinant protein, Escherichia coli, NMR
Protein & Peptide Letters
Title: Expression and Purification of Uniformly 15N-Labeled Amyloid β Peptide 1-40 in Escherichia coli
Volume: 14 Issue: 8
Author(s): M. Nagata-Uchiyama, M. Yaguchi, Y. Hirano and T. Ueda
Affiliation:
Keywords: Alzheimer's disiease, amyloid β 1-40, amyloid fibrils, recombinant protein, Escherichia coli, NMR
Abstract: For biophysical studies using heteronuclear NMR analysis of amyloid beta peptide, construction of an efficient and high yield expression system of uniformly isotopic labeled amyloid beta peptide is desirable. Here we succeeded in obtaining 15N-labeled amyloid beta 1-40 expressed by attachment to hen egg white lysozyme as a fusion protein.
Export Options
About this article
Cite this article as:
M. Nagata-Uchiyama , M. Yaguchi , Y. Hirano and T. Ueda , Expression and Purification of Uniformly 15N-Labeled Amyloid β Peptide 1-40 in Escherichia coli, Protein & Peptide Letters 2007; 14 (8) . https://dx.doi.org/10.2174/092986607781483741
DOI https://dx.doi.org/10.2174/092986607781483741 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Incorporating Natural Products, Pharmaceutical Drugs, Self-Care and Digital/Mobile Health Technologies into Molecular-Behavioral Combination Therapies for Chronic Diseases
Current Clinical Pharmacology Short- and Long-Term Survival of Nonsurgical Intensive Care Patients and its Relation to Diagnosis, Severity of Disease, Age and Comorbidities
Current Aging Science Diagnosis of Autism Spectrum Disorder in Adolescents with Complex Clinical Presentations: A Montreal Case Series
Adolescent Psychiatry Multi-Target-Directed Ligands Affecting Serotonergic Neurotransmission for Alzheimer’s Disease Therapy: Advances in Chemical and Biological Research
Current Medicinal Chemistry Adenosine and ATP Receptors in the Brain
Current Topics in Medicinal Chemistry Tribute to Prof. Gerald Farin: Remembering A Geometric Modeling Researcher and Educator
Neuroscience and Biomedical Engineering (Discontinued) Control of Eosinophil Toxicity in the Lung
Current Drug Targets - Inflammation & Allergy Chemical Senses in Cancer Patients
Current Pharmaceutical Design New Targets for Treating the Underlying Pathophysiology and Nonmotor Aspects of Parkinson's Disease
CNS & Neurological Disorders - Drug Targets Primary Progressive Aphasia-Defining Genetic and Pathological Subtypes
Current Alzheimer Research subject Index To Volume 1
Current Medicinal Chemistry - Central Nervous System Agents Patent Review
Combinatorial Chemistry & High Throughput Screening Contemporary Progress in the Synthesis and Reaction of 2-Arylbenzothiazole: A Review
Current Organic Chemistry Winning a Won Game: Caffeine Panacea for Obesity Syndemic
Current Neuropharmacology Meet Our Editor
Current Metabolomics Development of Cathepsin Inhibitors and Structure-Based Design of Cathepsin B-Specific Inhibitor
Current Topics in Medicinal Chemistry Classification of Sarcomas Using Bioinformatics and Molecular Profiling
Current Pharmaceutical Biotechnology Protein Kinase C as a Drug Target Implications for Drug or Diet Prevention and Treatment of Cancer
Current Drug Targets Quantitative Enzymology
Current Enzyme Inhibition Impact of Sphingosine Kinase on Inflammatory Pathways in Fibroblast-Like Synoviocytes
Inflammation & Allergy - Drug Targets (Discontinued)